Substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines - a promising class of lipoxygenase inhibitors

The modern strategy of potential biologically active molecules search ("drug-design") is based on several innovation approaches. The method of high thrоughрut biological screening and method of molecular modeling deserves the most attention among such approaches. Lipoxygenase (LOX) is one...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Stavytskyi (Author), I. S. Nosulenko (Author), O. O. Portna (Author), V. M. Shvets (Author), O. Yu. Voskoboynik (Author), S. І. Kоvalenko (Author)
Format: Book
Published: Zaporozhye State Medical University, 2020-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c078a3ea02da40b8b881efd3d355cf3e
042 |a dc 
100 1 0 |a V. V. Stavytskyi  |e author 
700 1 0 |a I. S. Nosulenko  |e author 
700 1 0 |a O. O. Portna  |e author 
700 1 0 |a V. M. Shvets  |e author 
700 1 0 |a O. Yu. Voskoboynik  |e author 
700 1 0 |a S. І. Kоvalenko  |e author 
245 0 0 |a Substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines - a promising class of lipoxygenase inhibitors 
260 |b Zaporozhye State Medical University,   |c 2020-05-01T00:00:00Z. 
500 |a 10.14739/2409-2932.2020.1.198109 
500 |a 2306-8094 
500 |a 2409-2932 
520 |a The modern strategy of potential biologically active molecules search ("drug-design") is based on several innovation approaches. The method of high thrоughрut biological screening and method of molecular modeling deserves the most attention among such approaches. Lipoxygenase (LOX) is one owf the most perspective biological target for the substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines. So, molecular docking towards LOX and enzyme activating activity was investigated. The aim: Directed search of potential inhibitors of lipoxygenases among the unknown pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines with the use of molecular docking and in vitro high throughput screening. Materials and methods. The research of lipoxygenase activity has been conducted for a number of original pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines. Standard software was used for molecular docking and "drug-like" criteria research. Sodium letinate was used as a substrate to study soybean LOX enzyme activating activity. Results. The results of molecular docking have shown, that substituted pyrrolo[1,2-a][1,2,4]triazolo[1,5-c]quinazolines reveal a strong affinity toward LOX. The main types of interactions with aminoacid residues of mentioned the enzyme were identified. The conducted researches showed, that the substituted pyrrolo[1,2-a][1,2,4]triazino[2,3-c]quinazolines had the highest soybean LOX inhibition activity. Compounds with a fluorine atom and a 2-thienyl moiety in the structure revealed the highest activity inhibiting lipoxygenase by 36.33 % and 39.83 % respectively. The increased lipophilicity of triazine derivatives promotes a higher ability to inhibit soybean LOX, whereas, for triazole derivatives, which have lower molecular weight, an inverse relation is observed. Conclusions. The research of the substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines inhibition ability of soybean LOX as one of the possible mechanisms of their activity is proved and conducted. It is shown, that their lipoxygenase activity depends on lipophilicity and is defined by the availability of donor-acceptor fragments in the molecule, that is capable to form hydrogen and other types of interaction. The specified results are strong arguments for their further study as promising anti-inflammatory agents. 
546 |a EN 
546 |a RU 
546 |a UK 
690 |a drug discovery 
690 |a pyrrolo[1 2-a][1 2 4]triazolo-(triazino-)[c]quinazolines 
690 |a molecular docking 
690 |a lipoxygenase activity 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, Vol 13, Iss 1, Pp 4-10 (2020) 
787 0 |n http://pharmed.zsmu.edu.ua/article/view/198109/199112 
787 0 |n https://doaj.org/toc/2306-8094 
787 0 |n https://doaj.org/toc/2409-2932 
856 4 1 |u https://doaj.org/article/c078a3ea02da40b8b881efd3d355cf3e  |z Connect to this object online.